Rigetti (RGTI) Stock Jumps 19% Ahead of Earnings. Can the Rally Continue?
π Rigetti shares jumped 19.29% to close at $11.75 ahead of Q3 2026 earnings, though the stock is still down nearly 47% year-to-date.
π° Analysts expect a Q3 loss of $0.05 per share and revenue of approximately $3.67 million, up from $1.95 million last year.
𧬠Rigetti's Cepheus quantum system achieved 99.1% median two-qubit gate fidelity with a target of 99.5% by the end of 2026.
π€ The company secured an $8.4 million order from India's C-DAC for its 108-qubit quantum computer, expected to be recognized in Q4.
ποΈ Rigetti signed a definitive $100 million agreement with the U.S. Department of Commerce for superconducting quantum-computing research.
πΈ Operating expenses rose 49% year-over-year to $30.3 million in Q2 due to increased investment in research and manufacturing.
π Wall Street maintains a Strong Buy consensus rating with an average price target of $24, implying roughly 104% upside.
- Rigetti shares surged 19.29% to close at $11.75 ahead of earnings, driven by sector-wide optimism following IonQ's blockbuster results.
- The company achieved 99.1% median two-qubit gate fidelity on its Cepheus system, targeting an improvement to 99.5% by the end of 2026.
- Rigetti secured an $8.4 million order from India's C-DAC for a 108-qubit quantum computer, with revenue expected in Q4.
- The firm signed a definitive $100 million agreement with the U.S. Department of Commerce to support its superconducting quantum-computing research.
- Analysts maintain a Strong Buy consensus rating based on three Buy ratings issued over the past three months.
- The average price target of $24 implies approximately 104% upside from Friday's closing price, indicating strong Wall Street bullishness.
- Rigetti is expected to report a Q3 loss of $0.05 per share, widening the net loss to $52.6 million in the prior quarter.
- Operating expenses reached $30.3 million in Q2, up nearly 49% year-over-year, as the company invested heavily in research and new equipment.
- Despite impressive revenue growth of 183% in Q2, rising costs have continued to pressure the stock price.